Log In
BCIQ
Print this Print this
 

Hepatitis B vaccine (MGN1333)

  Manage Alerts
Collapse Summary General Information
Company Mologen AG
DescriptionDNA-based vaccine against hepatitis B
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: DNA vaccine
Latest Stage of DevelopmentPreclinical
Standard IndicationHepatitis B virus (HBV)
Indication DetailsPrevent hepatitis B virus (HBV) infection
Regulatory Designation
PartnerSynvolux Therapeutics B.V.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today